Reckitt Benckiser Group plc (LON:RKT - Get Free Report)'s stock price rose 9.9% during mid-day trading on Friday . The stock traded as high as GBX 5,232 ($67.85) and last traded at GBX 5,148.73 ($66.77). Approximately 373,139,531 shares changed hands during mid-day trading, an increase of 7,325% from the average daily volume of 5,025,405 shares. The stock had previously closed at GBX 4,684 ($60.74).
RKT has been the topic of several research analyst reports. Berenberg Bank dropped their price objective on Reckitt Benckiser Group from GBX 5,200 ($67.44) to GBX 5,177 ($67.14) and set a "hold" rating on the stock in a research note on Wednesday, October 23rd. JPMorgan Chase & Co. downgraded Reckitt Benckiser Group to a "neutral" rating in a research report on Friday, August 30th. Finally, Jefferies Financial Group reaffirmed a "hold" rating and issued a GBX 4,400 ($57.06) target price on shares of Reckitt Benckiser Group in a research report on Monday, July 29th.
Check Out Our Latest Report on RKT
The firm has a 50-day moving average price of GBX 4,599.06 and a 200 day moving average price of GBX 4,442.80. The company has a debt-to-equity ratio of 112.52, a current ratio of 0.69 and a quick ratio of 0.46. The company has a market cap of £35.50 billion, a price-to-earnings ratio of 2,158.53, a P/E/G ratio of 1.10 and a beta of 0.09.
In related news, insider Fiona Dawson purchased 25 shares of Reckitt Benckiser Group stock in a transaction that occurred on Wednesday, October 23rd. The shares were acquired at an average price of GBX 4,923 ($63.84) per share, with a total value of £1,230.75 ($1,596.10). 0.05% of the stock is owned by company insiders.
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.